Article Details
Retrieved on: 2021-08-30 12:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
30, 2021 /PRNewswire/ -- ImpediMed Limited (ASX:IPD), a global medical technology company using bioimpedance spectroscopy (BIS) to generate powerful data to ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here